You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NTRK gene fusion

Showing 1 - 25 of 7,543
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Learn More About NTRK Gene Fusion Positive in Solid Tumor in

Not yet recruiting
  • Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
  • No Drug
  • Multiple Locations, Japan
    Many Locations
Mar 20, 2023

NTRK Gene Fusion - Positive Advanced or Recurrent Solid

Recruiting
  • Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
  • Larotrectinib (Vitrakvi, BAY2757556)
  • Multiple Locations, Japan
    Many locations
Jan 20, 2023

A Retro-/Prospective, Non-interventional, Cohort Study in Adult

Active, not recruiting
  • Solid Tumor, Adult
  • +2 more
    • Amiens, France
    • +3 more
    Jul 22, 2022

    Solid Tumors Harboring NTRK Fusion Trial (Selitrectinib (BAY2731954))

    No longer available
    • Solid Tumors Harboring NTRK Fusion
    • Selitrectinib (BAY2731954)
    • (no location specified)
    Sep 8, 2021

    Called EPI VITRAKVI to Compare Treatment Results in Infantile

    Completed
    • Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion
    • Infantile Fibrosarcoma
    • Larotrectinib (Vitrakvi, BAY2757556)
    • Standard of Care
    • Multiple Locations, France
      Multiple Locations
    Jan 10, 2023

    NTRK Gene Fusion in Adult Brain Tumours

    Not yet recruiting
    • Glioma
    • Glioma data collection
    • Brain metastasis data collection
    • Marseille, France
      Hôpital Privé Clairval
    Aug 24, 2021

    NTRK Family Gene Mutation Trial in Germany

    Recruiting
    • NTRK Family Gene Mutation
      • Berlin, Germany
      • +22 more
      Jan 18, 2023

      Solid Tumor Trial in Beijing (AB-106)

      Recruiting
      • Solid Tumor
      • Beijing, China
        Chinese PLA General Hospital
      Jun 18, 2021

      Locally Advanced or Metastatic Solid Tumors, Locally Advanced or Metastatic NSCLC Trial in Beijing (XZP-5955 tablets)

      Recruiting
      • Locally Advanced or Metastatic Solid Tumors
      • Locally Advanced or Metastatic Non-small Cell Lung Cancer
      • XZP-5955 tablets
      • Beijing, Beijing, China
        Cancer Hospital Chinese Academy of Medical Sciences
      May 17, 2022

      Advanced Solid Malignant Tumors Trial in Fukuoka, Osaka, Tokyo (DS-6051b)

      Active, not recruiting
      • Advanced Solid Malignant Tumors
      • Fukuoka, Japan
      • +2 more
      Jan 18, 2022

      Cancer, Cancer Metastatic, NTRK Gene Fusion Overexpression Trial in Worldwide (Data collection and quality of life

      Recruiting
      • Cancer
      • +15 more
      • Data collection and quality of life questionnaire
      • Graz, Austria
      • +40 more
      Jul 27, 2021

      Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion Trial in Shanghai (SIM1803-1A)

      Recruiting
      • Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion
      • Shanghai, China
        Shanghai Chest Hospital
      Jan 11, 2021

      Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer

      Recruiting
      • Thyroid Cancer
      • NTRK fusion assessment
      • Roma, Italy
        Regina Elena National Cancer Institute
      Mar 31, 2023

      Tumors Harboring NTRK Fusion Trial (Larotrectinib (Vitrakvi, BAY2757556))

      Approved for marketing
      • Tumors Harboring NTRK Fusion
      • Larotrectinib (Vitrakvi, BAY2757556)
      • (no location specified)
      Dec 18, 2019

      Solid Tumor Trial (TL118 Capsule)

      Not yet recruiting
      • Solid Tumor
      • TL118 Capsule
      • (no location specified)
      Aug 18, 2023

      Called VICTORIA to Learn More About How Well Larotrectinib Works

      Active, not recruiting
      • Solid Tumors Harboring NTRK Fusion
      • Larotrectinib(Vitrakvi, BAY2757556)
      • Data on other treatments
      • Whippany, New Jersey
        Bayer
      Aug 22, 2022

      High Grade Glioma, Diffuse Intrinsic Pontine Glioma Trial in Worldwide (Larotrectinib, Larotrectinib surgical)

      Recruiting
      • High Grade Glioma
      • Diffuse Intrinsic Pontine Glioma
      • Aurora, Colorado
      • +17 more
      Aug 10, 2022

      Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma, Neoadjuvant or Conversion Therapy, Precision Therapy Trial in

      Recruiting
      • Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma
      • +2 more
      • Beijing, Beijing, China
      • +1 more
      Nov 21, 2023

      Glioblastoma Trial in Beijing (PLB1001, Temozolomide, Cisplatin combined with Etoposide)

      Active, not recruiting
      • Glioblastoma
      • Beijing, Beijing, China
        Beijing Tiantan Hospital,Capital Medical University
      Oct 27, 2023

      Solid Tumor, Adult, Brain Tumor, Primary, Desmoplastic Small Round Cell Tumor Trial in Australia, Korea, Republic of, United

      Recruiting
      • Solid Tumor, Adult
      • +2 more
      • Santa Monica, California
      • +11 more
      Jul 27, 2022

      Solid Tumors Trial (afatinib)

      No longer available
      • Solid Tumors
      • (no location specified)
      Nov 7, 2022

      Advanced Solid Tumors Harboring NTRK Fusion, Primary CNS Tumors Harboring NTRK Fusion Trial in Guangzhou (ICP-723)

      Recruiting
      • Advanced Solid Tumors Harboring NTRK Fusion
      • Primary Central Nervous System Tumors Harboring NTRK Fusion
      • Guangzhou, Guangdong, China
        Sun Yat-Sen University Cancer Center
      Feb 16, 2023

      Solid Tumors Harboring NTRK Fusion Trial in Worldwide (Larotrectinib (Vitrakvi, BAY2757556))

      Recruiting
      • Solid Tumors Harboring NTRK Fusion
      • Larotrectinib (Vitrakvi, BAY2757556)
      • Los Angeles, California
      • +50 more
      Jan 29, 2023

      Soft Tissue Sarcoma, Advanced Cancer, Metastatic Cancer Trial in France (Blood and tumor samples)

      Recruiting
      • Soft Tissue Sarcoma
      • +2 more
      • Blood and tumor samples
      • Clermont-Ferrand, France
      • +9 more
      Dec 8, 2021

      Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit

      Not yet recruiting
      • Helicobacter Pylori Infection
      • +3 more
      • Detection of fecal samples with diagnostic kit
      • +2 more
      • (no location specified)
      Jun 5, 2022